AxenTispHarmA.com

Rating: 0 - 0 votes

Company Name

Company Contact

Website Analysis

Domain Whois

Powered by who.is

Page Type

This page is about a company.

About AxenTispHarmA.com

Axentis Pharma AG is a Swiss Biotech company. The company owns propietary technology which is applicable to correcting diseases for which the etiology is misrouted or misfolded proteins, such as cystic fibrosis, nephrogenic diabetes insipidus, familial hypercholesterolemia, retinitis pigmentosa or long-QT-syndrom.

Under an exclusive license agreement with aRigen Pharmaceuticals, Inc., Axentis Pharma develops ARB-CF0223 which is currently in clinical Phase II.

Domain Resolution

This domain resolves to the following IP addresses:


Rating: 0 - 0 votes

Company Name

Company Contact

Website Analysis

Domain Whois

Powered by who.is

Page Type

This page is about a company.

Retrieved from "http://aboutus.com/index.php?title=AxenTispHarmA.com&oldid=59600576"